ITRM stock · REG stock

ITRM vs REG · rev $390.0K vs P/E 34, $12.93B cap

Iterum Therapeutics PLC (ITRM) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.

Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.

Regency Centers Corporation (REG) is a reit - retail company listed on US.

Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.

REG does not have a complete income-statement cache yet.

ITRM currently screens at market cap $38.6M. REG currently screens at market cap $12.93B and trailing P/E 33.5.

Not investment advice. Open the ITRM and REG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons